Quantinno Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1M Buy
2,487,376
+477,128
+24% +$5.96M 0.05% 505
2025
Q4
$26M Buy
2,010,248
+488,080
+32% +$6.27M 0.05% 431
2025
Q3
$19.7M Buy
1,522,168
+153,505
+11% +$2.05M 0.05% 410
2025
Q2
$24.4M Buy
1,368,663
+380,411
+38% +$6.63M 0.11% 204
2025
Q1
$17.6M Buy
988,252
+693,613
+235% +$15.8M 0.11% 185
2024
Q4
$8.78M Buy
294,639
+43,108
+17% +$912K 0.09% 242
2024
Q3
$3.93M Sell
251,531
-102,925
-29% -$1.87M 0.05% 467
2024
Q2
$6.07M Buy
354,456
+297,183
+519% +$5.23M 0.11% 177
2024
Q1
$895K Buy
57,273
+31,831
+125% +$468K 0.02% 770
2023
Q4
$380K Buy
+25,442
New +$340K 0.01% 896
2021
Q2
Sell
-1,693
Closed -$224K 247
2021
Q1
$224K Hold
1,693
0.24% 223
2020
Q4
$293K Sell
1,693
-798
-32% -$109K 0.23% 233
2020
Q3
$277K Buy
+2,491
New +$199K 0.19% 286
2020
Q2
Sell
-5,002
Closed -$337K 413
2020
Q1
$337K Buy
+5,002
New +$395K 0.21% 257

Other funds holding NVCR